Ricettore IL
I recettori dell'interleuchina (recettori IL) sono un gruppo di recettori che si legano alle interleuchine, una famiglia di citochine che svolgono ruoli essenziali nella regolazione del sistema immunitario, nell'infiammazione e nell'ematopoiesi. La disregolazione della segnalazione delle interleuchine è associata a varie malattie infiammatorie e autoimmuni, rendendo i recettori IL bersagli critici per l'intervento terapeutico. Gli antagonisti dei recettori IL sono studiati per il trattamento di condizioni come l'artrite reumatoide, la psoriasi e le malattie infiammatorie intestinali. Presso CymitQuimica, offriamo una gamma di modulatori dei recettori IL di alta qualità per supportare la tua ricerca sulla segnalazione delle citochine, sull'immunologia e sulla terapia delle malattie infiammatorie.
Trovati 85 prodotti di "Ricettore IL"
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
YQ128
CAS:YQ128 is a potent and selective inhibitor of second-generation NLRP3 (NOD-like receptor P3) inflammasome(IC50 of 0.30 µM), with anti-inflammatory activity.Formula:C27H29ClN2O4S2Purezza:99.89%Colore e forma:SolidPeso molecolare:545.11Ref: TM-T13375
1mg52,00€5mg113,00€10mg177,00€25mg289,00€50mg485,00€100mg700,00€1mL*10mM (DMSO)137,00€Vunakizumab
CAS:Vunakizumab is a humanized IgGκ monoclonal antibody targeting IL-17A, often linked to interleukin 22 to form Vunakizumab-IL22.Purezza:95%Colore e forma:LiquidPeso molecolare:146.38 kDaElsilimomab
CAS:Elsilimomab (B-E8) is a monoclonal antibody targeting IL-6, inhibiting the induction of bone marrow stromal cell senescence by dnmt3a mutation clones.Purezza:>95%Colore e forma:LiquidPeso molecolare:145.96 kDaIxekizumab
CAS:Ixekizumab: IgG4 antibody, neutralizes IL-17A (<3 pM), treats severe plaque psoriasis & arthritis.Purezza:98.86% (SEC-HPLC) - > 99.3% (SDS-PAGE); 95.4% (SEC-HPLC)Colore e forma:LiquidPeso molecolare:146.2 kDaSarilumab
CAS:Sarilumab: Potent IL-6 blocker, human antibody, reduces inflammation, treats rheumatoid arthritis.Purezza:97.4%Colore e forma:LiquidPeso molecolare:144.12 kDaPF-07038124 HCl
CAS:PF-07038124 HCl is a selective and potent PDE4 inhibitor with an IC50 of 0.5 nM for PDE4B2.PF-07038124 HCl inhibits IL-13, IL-4, and IFNγ, and can be used in the study of skin disorders such as atopic dermatitis and plaque psoriasis.Formula:C18H23BClNO4Purezza:97.34% - 99.13%Colore e forma:SoildPeso molecolare:363.64Bermekimab
CAS:Bermekimab (MABp1), an anti-interleukin-1α (IL-1α) monoclonal antibody.Bermekimab has potential anti-inflammatory activity to prevent skin inflammation.Colore e forma:LiquidPeso molecolare:145.45 kDaAnti-IL-6R Reference Antibody (Vobarilizumab-Fc)
CAS:Vobarilizumab (ALX-0061) is a humanized specific antibody targeting IL-6R and ALB, used in research on autoimmune diseases like rheumatoid arthritis.Purezza:>95%Colore e forma:LiquidPeso molecolare:78.2 kDaBriakinumab
CAS:Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the research of psoriasis multiple sclerosis.Purezza:>95%Colore e forma:LiquidPeso molecolare:143.86 kDaNidanilimab
CAS:Nidanilimab (CAN04) is an IL1RAP antibody with 1.10 pM affinity and antitumor effects on NSCLC and PDAC.
Purezza:> 95%Colore e forma:SoildPeso molecolare:150 kDaSpesolimab
CAS:Spesolimab (BI 655130) is an antibody targeting IL-36 receptor, key in immunity, for systemic pustular psoriasis and dermatitis studies.Purezza:> 95%Colore e forma:LiquidPeso molecolare:150 kDaRisankizumab
CAS:Risankizumab (BI 655066) is a monoclonal antibody for psoriasis, targeting IL-23, with high affinity (Kd <10 pM) and an IC50 of 2 pM.Purezza:SDS-PAGE:95.3%;SEC-HPLC:98.3%Colore e forma:LiquidPeso molecolare:145.85 kDaSiltuximab
CAS:Siltuximab（CNTO-328） is a monoclonal antibody with anti-tumor activity targeting IL-6 for the study of giant lymph node hyperplasia (MCD) and COVID-19.Purezza:100% (SEC-HPLC) - > 95%Colore e forma:LiquidPeso molecolare:144.98 kDa2-Benzothiazolamine
CAS:2-ABT: nitrogen-rich heterocycle used in drug synthesis, inhibits P450, with anti-inflammatory, anticonvulsant, anticancer properties.Formula:C7H6N2SPurezza:99.09% - 99.3%Colore e forma:Plates From Water Physical Description Odorless Gray To White Powder (Ntp 1992)Peso molecolare:150.2Brodalumab
CAS:Brodalumab (AMG 827), a human IgG2 monoclonal antibody, inhibits IL-17R, treating psoriasis.Purezza:98.3%Colore e forma:LiquidPeso molecolare:144.06 kDaEnokizumab
CAS:Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.
Purezza:SDS-PAGE:95% SEC-HPLC:99.23%Colore e forma:LiquidPeso molecolare:145.98 kDaIL-15-IN-1
CAS:IL-15-IN-1 is a selective and potent Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells (IC50: 0.8 μM).Formula:C30H36N6O4SPurezza:99.16%Colore e forma:SolidPeso molecolare:576.71Ref: TM-T11634
1mg88,00€5mg170,00€10mg259,00€25mg429,00€50mg605,00€100mg815,00€200mg1.093,00€1mL*10mM (DMSO)210,00€Ordesekimab
CAS:Ordesekimab (AMG 714) is a human anti-IL-15 IgG1 κ monoclonal antibody for studying NRCD.Purezza:> 95%Colore e forma:LiquidPeso molecolare:145.12 kDaTildrakizumab
CAS:Tildrakizumab (SCH 900222) is a humanized antibody against IL-23, with a 136 pM Kd, used for psoriasis research.Purezza:> 95%Colore e forma:LiquidPeso molecolare:144.44 kDaTorudokimab
Torudokimab (ZB-880) is a monoclonal antibody that neutralizes interleukin 33 and can be used to study immune system diseases.Purezza:95.8% (SDS-PAGE); 96.2% (SEC-HPLC) - 95.8% (SDS-PAGE); 96.2% (SEC-HPLC)Colore e forma:LiquidPeso molecolare:144.71 kDa
